VIDEO: Early data on new treatments for dry AMD ‘show promise’
Click Here to Manage Email Alerts
Anthony DeWilde OD, FAAO, director of the tele-eye imaging program at VA Kansas City Health Care, discusses a presentation at Academy that focused on geographic atrophy in age-related macular degeneration.
In this Healio video, DeWilde noted that early data on two new treatments “show promise” in slowing disease progression in these patients.
“For me, seeing patients in the low-vision clinic, geographic atrophy tends to be the most profound vision loss in AMD and these patients really suffer from it. Anything to help them would be super beneficial,” he said. “We’ve had so much innovation in the form of anti-VEGF for wet AMD, but [for] the 90% of people who don’t get wet AMD, we need something for them.”